1. Home
  2. MXCT vs NCV Comparison

MXCT vs NCV Comparison

Compare MXCT & NCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • NCV
  • Stock Information
  • Founded
  • MXCT 1999
  • NCV 2003
  • Country
  • MXCT United States
  • NCV United States
  • Employees
  • MXCT N/A
  • NCV N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NCV Finance Companies
  • Sector
  • MXCT Health Care
  • NCV Finance
  • Exchange
  • MXCT Nasdaq
  • NCV Nasdaq
  • Market Cap
  • MXCT 375.0M
  • NCV 326.2M
  • IPO Year
  • MXCT 2021
  • NCV N/A
  • Fundamental
  • Price
  • MXCT $4.11
  • NCV $3.51
  • Analyst Decision
  • MXCT Strong Buy
  • NCV
  • Analyst Count
  • MXCT 2
  • NCV 0
  • Target Price
  • MXCT $9.50
  • NCV N/A
  • AVG Volume (30 Days)
  • MXCT 558.7K
  • NCV 405.1K
  • Earning Date
  • MXCT 11-06-2024
  • NCV 01-01-0001
  • Dividend Yield
  • MXCT N/A
  • NCV 12.48%
  • EPS Growth
  • MXCT N/A
  • NCV N/A
  • EPS
  • MXCT N/A
  • NCV N/A
  • Revenue
  • MXCT $45,599,000.00
  • NCV N/A
  • Revenue This Year
  • MXCT N/A
  • NCV N/A
  • Revenue Next Year
  • MXCT $21.27
  • NCV N/A
  • P/E Ratio
  • MXCT N/A
  • NCV N/A
  • Revenue Growth
  • MXCT 19.85
  • NCV N/A
  • 52 Week Low
  • MXCT $3.17
  • NCV $2.84
  • 52 Week High
  • MXCT $5.55
  • NCV $3.59
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 55.35
  • NCV 43.52
  • Support Level
  • MXCT $3.98
  • NCV $3.62
  • Resistance Level
  • MXCT $4.41
  • NCV $3.61
  • Average True Range (ATR)
  • MXCT 0.27
  • NCV 0.07
  • MACD
  • MXCT -0.00
  • NCV -0.02
  • Stochastic Oscillator
  • MXCT 54.64
  • NCV 21.43

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About NCV Virtus Convertible & Income Fund of Beneficial Interest

Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.

Share on Social Networks: